Ryan Beal: Co-Founder and CEO of Dyve Biosciences
Ryan Beal, CEO of Dyve Biosciences, shares his insights about leadership in biopharma and how Dyve is working to deliver targeted pH modulation to treat a range of immunologic and oncologic diseases.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.